0000000000803120

AUTHOR

M. D. Ramon

showing 4 related works from this author

Dermoscopic characteristics of a cutaneous histiocytic sarcoma in a young patient

2017

Adultmedicine.medical_specialtySkin Neoplasmsbusiness.industryJuvenile xanthogranulomaBreast NeoplasmsDermoscopyDermatologyHistiocytic sarcomamedicine.diseaseDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisHumansMedicineFemaleHistiocytic SarcomabusinessHistiocyteJournal of the American Academy of Dermatology
researchProduct

Cutaneous manifestations in COVID‐19: a new contribution

2020

Abstract We have read with great interest Dr Recalcati’s review about skin manifestations in COVID‐19 as it is the first report on this subject1. In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases2. However, from the trained eyes of a dermatologist, this percentage may be higher.

2019-20 coronavirus outbreakmedicine.medical_specialtyskinCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyLetter to Editor030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineCOVID‐19medicineSkin manifestationscutaneous manifestationsbusiness.industrycutaneousmedicine.diseaseDermatologyRashPneumoniaInfectious Diseases030220 oncology & carcinogenesisDifferential diagnosismedicine.symptombusinessCoronavirus InfectionsJournal of the European Academy of Dermatology and Venereology
researchProduct

Levetiracetam‐induced pediatric toxic epidermal necrolysis successfully treated with etanercept

2020

Successful management of toxic epidermal necrolysis (TEN) with tumor necrosis factor-α inhibitors has been described in adults, but few cases have been reported in children. To date, only four pediatric cases of TEN treated with infliximab and one with etanercept have been published. We present the case of an 8-year-old boy diagnosed with TEN induced by levetiracetam, successfully treated with etanercept, systemic corticosteroids, and intravenous immunoglobulin.

musculoskeletal diseasesmedicine.medical_specialtybiologybusiness.industryDermatologymedicine.diseaseDermatologyToxic epidermal necrolysisInfliximabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPediatrics Perinatology and Child Healthbiology.proteinmedicineTumor necrosis factor alphaLevetiracetamAntibodyskin and connective tissue diseasesbusinessmedicine.drugPediatric Dermatology
researchProduct

A pigmented and eroded lesion on the buttock.

2019

Aged 80 and overmedicine.medical_specialtyKeratosisbusiness.industrymedicine.medical_treatmentDermatologyEccrine Porocarcinomamedicine.diseaseMohs SurgeryDermatologyLesionSweat Gland NeoplasmsText miningMohs surgerymedicineButtocksHumansFemalemedicine.symptombusinessSkin pathologyKeratosis SeborrheicSkinClinical and experimental dermatologyReferences
researchProduct